500,000
Participants
Start Date
March 5, 2024
Primary Completion Date
December 1, 2026
Study Completion Date
December 30, 2028
Parkland Diabetes Detection Program (PDDP) Screening Invitation
"The PDDP is designed to supplement and close screening gaps that persist despite opportunistic screening. Program staff order diabetes screening tests for randomized patients, then mail screening invitation letters to inform patients that they are at risk for diabetes. The letter informs them that a screening test has been ordered, and requests that they complete testing at their clinic lab. Patients who were mailed the letter but have not completed screening after 30 days are tracked and are send a second reminder invitation. Patients randomized to the targeted-tailored intervention study arm receive an additional phone call after 30 days."
Parkland Health, Dallas
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
University of Texas Southwestern Medical Center
OTHER